Zusammenfassung
Die Erkenntnis, daß manche Erkrankungen der Niere mit einer Störung des Fettstoffwechsels bzw. einer milchigen Trübung des Plasmas einhergehen können, wurde schon sehr früh von Blackall (1813) und Bright (1927) gewonnen. Die Pathogenese dieser Störung konnte jedoch bis heute noch nicht voll aufgeklärt werden. Bönninger (1901) gelang zunächst der Nachweis, daß tatsächlich die Blutfette bei einem Nierenkranken erhöht waren, während eine Erhöhung des Serumcholesterins, der Triglyceride oder der Phospholipide erst in späteren differenzierten Untersuchungen gezeigt werden konnte (Eppstein, 1917; Daniels, 1925; Page, 1936; Peters u. Man, 1943; Thomas, 1951).
This is a preview of subscription content, log in via an institution.
Buying options
Tax calculation will be finalised at checkout
Purchases are for personal use only
Learn about institutional subscriptionsPreview
Unable to display preview. Download preview PDF.
Literatur
Alfrey, A.C., Sussman, K.E., Holmes, J.H.: Changes in glucose and insulin metabolism induced by dialysis in patients with chronic uremia. Metabolism 16, 733 (1967).
Bagdade, J.D., Porte, D., Biermann, E.L.: Diabetic Lipemia: form of aquired fat-induced Lipemia. New Engl. J. Med. 276, 427.
Bagdade, J.D.: Uremic lipemia. Arch. intern. Med. 126, 875 (1970).
Bagdade, J.D., Porte, D., Biermann, E.L.: Hypertri-glyceridmia, a metabolic consequence of chronic renal failure. New Engl. J. Med. 279, 181 (1968).
Baxter, J.H., Goodman, H.C., Havel, R.J.: Serum lipid and lipoprotein alterations in nephrosis. J. clin. Invest. 39, 455 (1960).
Baxter, J.H., Goodman, H.C., Havel, R.J.: Hyperlipoproteinemia in nephrosis. Arch. intern. Med. 109, 146 (1962).
Beck, L.V., Fedynskj, N.: Evidence from combined immunoassay and radioautography procedures that intact insulin-J 125 molecules are concentrated by munse kidney proximal tubule cells. Endocrinology 81, 475 (1967).
Biermann, E.L.: Abnormialities of carbohydrate and lipid metabolism in Uremia. Arch. intern. Med. 126, 790 (1970).
Biermann, E.L., Porte, D.: Carbohydrate intolerance and lipemia. Ann. int. Med. 68, 926 (1968).
Bilheimer, D., Eisenberg, S., Levy, R.I.: Human plasma very low density lipoprotein metabolism. J. clin. Invest. 50, 8a (1971) (Abstr.).
Blackall, J.: Observations on the nature and cure of dropsies and particularly on the presence of the coagulable part of the blood in dropsical urine, p. 58, 98. London: Longman, Hurst, Rees, Orme, Browne 1813.
Bogdonoff, M.D., Linhart, J., Klein, R.F., Estes, E.H.: The effect of serum albumin infusion upon lipid mobilization in the nephrotic syndrome in man. J. clin. Invest. 40, 1024 (1961).
Bönninger, M.: Über die Methode der Fettbestimmung im Blut und den Fettgehalt des menschlichen Blutes. Z. klin. Med. 42, 65 (1901).
Boyer, J.L., Scheig, L.: Inhibition of postheparin lipolytic activity in uremia and its relationship to hypertriglyceridemia. Proc. Soc. exp. Biol. (N.Y.) 134, 603 (1970).
Brech, W., Piazolo, P., Franz, H.E., Schröder, K.E.: Untersuchungen des Glukosestoffwechsels bei Hämodialysen mit einem glukosefreien Dialysat. Ärztl. Forsch. 25, 287 (1971).
Brech, W., Shrago, E., Wilken, D.: Studies on pyruvate carboxylas! in rat and human liver. Biochim. biophys. Acta (Amst.) 201, 145 (1970).
Briggs, J.D., Buchanan, K.D., Luki, R.G., Mckiddie, M.T.: Role of insulin in glucose intolerance in uremia. Lancet 1967 I, 462.
Bright, R.: Reports of medical cases, selected with a view of illustrating the symptoms and cure of diseases by a reference to morbid anatomy, Vol. 1. London: Longman 1827.
Cerletty, J.M., Engbring, N.H.: Azotemia and carbohydrate intolerance. Clin. Res. 13, 423 (1965).
Chamberlain, M.J., Stimmler, L.: The renal handling of insulin. J. clin. Invest. 46, 911 (1967).
Cohnen, B.D., Horowitz, H.L.: Carbohydrate metabolism in uremia. Inhibition of phosphor release. Amer. J. clin. Nutr. 21, 407 (1968).
Daniels, W.B.: Plasma lipids in renal disease. Brit. J. exp. Path. 6, 283 (1925).
Davidson, M.B., Lowrie, E.G., Hampers, C.L.: Lack of dialysable insulin antagonist in uremia. Metabolism 18, 387 (1969).
Durrum, E.L.: In: A Manual of Paper Chromatography and Paper Electrophoresis, Second Ed. (Eds. Block, R.J., Durrum, E.L., Zweig, G.), p. 523. New York: Academic Press 1958.
Earley, L.E., Havel, R.J., Hopper, J., Gransz, H.: Nephrotic Syndrome. Calif. Med. 115, 23 (1971).
Edwards, K.D.G., Paoletti, R.: Hyperlipemia in experimental nephrosis and its control by chlorophen-oxy-isobutyrate and betabenzalbutyrate. Med. J. Aust. 1, 474 (1970).
Eppstein, A.A.: The nature and treatment of chronic parenchymatous nephritis (nephrosis). J. Amer. med. Ass. 69, 444 (1917).
Ford, F., Bozian, R.C., Knowles, H.C.: Interactions of obesity, insulin and glucose levels in hypertriglyceridemia. Clin. Res. 15, 428 (1967).
Giordano, C.: Use of exogenous and endogenous urea for protein synthesis in normal and uraemic patients. J. Lab. clin. Med. 62, 231 (1963).
Giovannetti, S., Maggiore, Q.: A low nitrogen diet with proteins of high biological value for severe chronic uraemia. Lancet 1964 I, 1000.
Gitlin, D., Cornwell, D.G., Nakasato, D., Onctey, J.L., Hughes, W.L., Janeway, C.A.: Studies on the metabolism of plasma proteins in the nephrotic syndrome. I. Lipoproteins. J. clin. Invest. 37, 172 (1958).
Goodmann, A.D., Fuisz, R.E., Cahill, G.F.: Renal gluconeogenesis in acidosis, alkalosis and potassium deficiency: Its possible role in regulation of renal ammonia production. J. clin. Invest. 45, 612 (1966).
Hamilton, R.L., Regen, D.M., Grag, M.E.: Lipid transport in liver. I. Electron microscopic identification of very low density lipoproteins in perfused rat liver. Lab. Invest. 16, 305 (1967).
Hampers, C.L., Stuart, J., Doak, P.B., Merrill, J.P.: Effect of chronic renal failure and hemodialysis on carbohydrate metabolism. J. clin. Invest. 45, 1719 (1966).
Hampers, C.L., Soeldner, J.S., Gleason, R.E., Bailey, G.L., Diamond, J.A., Merrill, J.P.: Insulin-glucose relationship in uremia. Amer. J. clin. Nutr. 5, 414 (1968).
Hatch, F.E., Parrish, A.E.: Apparent remission of a severe diabetic on developing the Kimmelstiel-Wilson syndrome. Ann. intern. Med. 54, 544 (1961).
Heymann, W., Hackel, D.B.: Role of kidney in pathogenesis of experimental nephrotic hyperlipemia in rats. Proc. Soc. exp. Biol. (N.Y.) 89, 329 (1955).
Heymann, W., Nash, G., Gilkey, C., Lewis, M.: Studies on the causal role of hypoaluminemia in experimental nephrosis. J. clin. Invest. 37, 808 (1958).
Horton, R.H., Johnson, C., Lebovitz, H.E.: Carbohydrate metabolism in uremia. Ann. intern. Med. 68, 63 (1968).
Hutchings, R.H., Hegstrom, R.M., Scribner, B.H.: Glucose intolerance in patients on long-term intermittend hemodialysis. Ann. intern. Med. 65, 275 (1966).
Kaess, H., Schlierf, G., Ehlers, W., von Mikulicz-Radecki, J.G., Walter, K., Brech, W., Hengstmann, J.: The carbohydrate metabolism of normal subjects during potassium depletion. Diabetologia 7, 82 (1971).
Kekki, M., Nikkilä, E.A.: Plasma triglyceride metabolism in the adult nephrotic syndrome. Europ. J. clin. Invest. 1, 345 (1971).
Klahr, S., Tripathy, K., Bolanos, O.: Qualitative and quantitative analysis of urinary lipids in the nephrotic syndrome. J. clin. Invest. 46, 1475 (1967).
Kluthe, R., Quirin, H.: Diätbuch für Nierenkranke. Stuttgart: Thieme 1971.
Lagrue, G., Halpern, B., Milliez, P., Branellac, A.: C. R. Soc. Biol. (Paris) 151, 1839 (1957).
Lewis, L.A., Page, I.H.: Electrophoretic and ultracen-trifugal analysis of serum lipoproteins in normal, nephrotic and hypertensive persons. Circulation 7, 707 (1953).
Lewis, L.A., Ziehlke, V., Nakomoto, S., Kolff, W.J., Page, I.H.: Renal regulation of α-Lipoproteins. Decrease of α -lipoproteins in the absence of renal function. New Engl. J. Med. 275, 1097 (1966).
Losowsky, M.S., Kenward, D.H.: Lipid metabolism in acute and chronic renal failure. J. Lab. clin. Med. 71, 736 (1968).
Mallrick, M.P., Berlyne, G.M.: Ischaemie heart disease developing in the nephrotic syndrome. Free Communications Abstracts. IVth. Int. Congr. Nephrol., Stockholm 1969.
Malmendier, C.L.: Le Métabolisme Lipidique dans le syndrome néphrotique. Coll. Médico-Monographies d’Agrégés. Bruxelles: Ed. Arscia S.A. 1969.
Marsh, J.B., Drabkin, D.L.: Experimental construction of metabolic pattern of lipid nephrosis: key role of hepatic protein synthesis in hyperlipemia. Metabolism 9, 946 (1960).
Marsh, N.A.: The fibrinolytic enzyme system of the rat. The effect of aminonucleosid-induced nephrotic syndrome. Brit. J. exp. Path. 50, 1 (1969).
McCann, W., Jude, J.R.: The synthesis of glucose by the kidney. Bull. Johns Hopk. Hosp. 103, 77 (1958).
Mirsky, I.A., Broh-Kahn, R.H.: The inactivation of insulin by tissue extracts. I. The distribution and properties of insulin inactivating extracts (insulinase). Arch. Biochem. 20, 1 (1949).
Nikkilä, E., Gräsbeck, R.: Heparin in lipoid nephrosis. Observations of the effects on edema, proteinuria serum proteins, Lipids, and Lipoproteins. Acta med. scand. 150, 39 (1954).
Page, I.H., Kirk, E., van Slyke, D.D.: Plasma lipids in chronic hemorrhagic nephritis. J. clin. Invest. 15, 101 (1936).
Perkoff, G.T., Thomas, C.L., Newton, J.D., Sellman, J.C., Tyler, F.H.: Mechanism of impaired glucose tolerance in uremia and experimental hyperazotemia. Diabetes 7, 375 (1958).
Peters, J.P., Man, E.B.: The interrelation-ship of serum lipids in patients with diseases of the kidneys. J. clin. Invest. 22, 271 (1943).
Peters, P., Gleischer, B., Fleischer, S.: The biosynthesis of rat albumin. IV. Apparent passage of albumin through the Golgi apparatus during secretion. J. biol. Chem. 216, 240 (1971).
Rabkin, R., Simon, N.M., Steiner, S., Colwell, J.A.: Effect of renal disease on renal uptake and excretion of insulin in man. New Engl. J. Med. 282, 182 (1970).
Reaven, G.M., Lerner, R.L., Stern, M. P., Farquhar, J.W.: Role of insulin in endogenous hypertriglyceridemia. J. clin. Invest. 46, 1756 (1967).
Reshef, L., Shapiro, B.: Fatty acid absorption by liver and adipose tissue particles. Biochim. Biophys. Acta 98, 73 (1965).
Reubi, F., Frankhauser,.: Le métabolisme des proteines et des lipides au cours de syndrome néphrotique 34. Congrès de médicines, Synd. Néphr. S. 64–87 (1963).
Rosenman, R.H., Friedman, M., Byers, S.O.: The causal role of plasma albumin deficiency in experimental nephrotic hyperlipemia and hypercholesterolemia. J. clin. Invest. 35, 522 (1956).
Rubenstein, A.H., Lowy, C., Fraser, R.T.: Radioimmunoassay of insulin in urine. Diabetologia, 3, 453 (1967).
Rubenstein, A.H., Spitz, I.: Role of the kidney in insulin metabolism and excretion. Diabetes 17, 161 (1968).
Runjan, J.W., Hurwitz, D., Robbins, S.L.: Effect of Kimmelstiel-Wilson-Syndrome on insulin requirements in diabetes. New Engl. J. Med. 252, 388 (1955).
Samaan, N.A., Freeman, R.M.: Growth-hormone levels in severe renal failure. Metabolism 19, 102 (1970).
Schrade, W.E., Böhle, E., Becker, G.: Über die Ausscheidung von Lipoprotein im Urin bei den soge-nannten Albuminurien. Dtsch. Arch. klin. Med. 202, 415 (1955).
Schreiner, G.E.: The nephrotic Syndrome. In: Diseases of the Kidney (Ed. Strauss, M.B., Welt, L.G.). Boston: Little Brown.
Schwarz, H., Kohn, J.L.: Lipid nephrosis. A clinical and pathological study based on 15 years observation with special reverence to prognosis. Amer. J. Dis. Child. 49, 579 (1935).
Spitz, I.M., Rubenstein, A.H., Bersohn, I., Abrahms, C., Lowy, C.: Carbohydrate metabolism in renal disease. Quart. J. Med. 39, 201 (1970).
Stein, O., Stein, Y.: Lipid synthesis, intracellular transport, storage and secretion. I. Electron microscopic antoradiographic study of liver after injection of tritiated palmitate or glycerol in fasted and ethanol treated rat. J. Cell Biol. 33, 319 (1967).
Takeda, Y., Chen, A.Y.: Fibrinogen metabolisma and distribution in patients with nephrotic syndrome. J. Lab. clin. Med. 70, 678 (1967).
Thomas, E.M., Rosenblum, A.H., Lander, H.B., Fisher, R.: Relationships between blood lipids and blood protein levels in the nephrotic syndrome. Amer. J. Dis. Child. 81, 207 (1951).
Tracy, R.E.: Lab. Invest. 13, 16 (1964).
Tschobroutsky, G., De L’hortet, G.C., Rosselin, G., Assan, R., Derot, M.: Studies on the glycoregulation in chronic renal insufficiency. Diabetologia 1, 101 (1965).
Westervelt, F.B.: Insulin effect in uremia. J. Lab. clin. Med. 74, 79 (1969).
Westervelt, F.B., Schreiner, G.E.: The carbohydrate intolerance of uremic patients. Ann. intern. Med. 57, 266 (1962).
Wreight, A.D., Lowy, C., Fraser, T.R., Spitz, I.M., Rubenstein, A.H.: Serum growth-hormone and glucose intoleance in renal failure. Lancet 1968 II, 798.
Zaharko, D.S., Beck, L.V., Blankenbaker, R.: Role of the kidney in the disposal of radioiodinated and non-radioiodinated insulin in dogs. Diabetes 15, 680 (1966).
Zimmer, J.G., Devey, R., Waterhouse, C., Terry, R.: The origin and nature of anisotropic urinary lipids in the nephrotic syndrome. Arch. intern. Med. 54, 205 (1961).
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 1979 Springer-Verlag Berlin · Heidelberg
About this chapter
Cite this chapter
Brech, W. (1979). Hyperlipidämie bei Erkrankungen der Niere. In: Assmann, G., et al. Fettstoffwechsel. Handbuch der inneren Medizin, vol 7 / 4. Springer, Berlin, Heidelberg. https://doi.org/10.1007/978-3-642-66302-4_16
Download citation
DOI: https://doi.org/10.1007/978-3-642-66302-4_16
Publisher Name: Springer, Berlin, Heidelberg
Print ISBN: 978-3-642-66303-1
Online ISBN: 978-3-642-66302-4
eBook Packages: Springer Book Archive